Krsnaa Diagnostics has received income tax appellate orders from the Commissioner of Income Tax (Appeals), Pune, covering Assessment Years 2017-18 through 2023-24. The aggregate disputed demand across these orders amounts to ₹62.69 crore. The company intends to file further appeals before the Income Tax Appellate Tribunal (ITAT).

The orders, issued under Section 250 of the Income-tax Act, 1961, represent the outcome at the first appellate level. Krsnaa Diagnostics stated that the underlying tax demands remain disputed and that it possesses adequate factual and legal grounds to substantiate its position before the ITAT. The company expects substantial relief in these proceedings based on advice from external tax experts.

Disputed Demand Breakdown

The appellate orders cover seven assessment years, with outcomes ranging from dismissal to partial allowance of appeals. The disputed demands as reflected in the Commissioner of Income Tax (Appeals) [CIT(A)] orders are detailed below.

Note: For AY 2022-23, the amount reflects the CIT(A) order dated August 28, 2026. A separate rectification order dated August 14, 2026, determined a revised balance payable of ₹31,73,28,734.

What the Numbers Show

The largest single-year disputed demand arises from AY 2022-23 at ₹19.63 crore, representing approximately 31% of the total aggregate disputed demand of ₹62.69 crore. This concentration highlights the significance of the recent assessment year in the overall litigation exposure. Additionally, four out of the seven assessment years resulted in the appeal being partly allowed, indicating some success at this appellate stage despite the continued dispute over the final amounts.

Operational Impact and Next Steps

Krsnaa Diagnostics confirmed that these matters do not impact its ongoing operations. The financial and accounting implications will be assessed and accounted for in accordance with applicable accounting standards. The company plans to file necessary appeals within prescribed timelines and will keep stock exchanges and shareholders informed of material developments.

This disclosure follows a previous intimation bearing reference no. KDL/SE/036/2026-27 dated August 26, 2026, regarding these ongoing income-tax proceedings.

Krsnaa Diagnostics has submitted its Business Responsibility and Sustainability Report (BRSR) for the financial year ended March 31, 2026, to the Bombay Stock Exchange and National Stock Exchange. The filing, dated September 5, 2026, discloses the company's environmental, social, and governance performance across its standalone operations.

The report highlights that the company operates 337 laboratories and 6,277 patient collection centers across 18 states. It details total revenue from operations of ₹6,909.47 crore and a net worth of ₹9,919.11 crore as per the CSR disclosures within the document.

Operational Footprint

As of March 31, 2026, Krsnaa Diagnostics maintained a workforce of 6,040 employees, comprising 3,296 permanent and 2,744 non-permanent staff. The gender distribution shows 53.16% male and 46.85% female employees among permanent staff. The company reported a turnover rate of 30.53% for permanent employees in FY26, up from 29.15% in FY25.

Environmental Metrics

The company reported a total energy consumption of 42,999 GJ in FY26, an increase from 41,362 GJ in the previous year. Non-renewable sources accounted for 42,767 GJ of this consumption. Greenhouse gas emissions (Scope 1 and Scope 2) totaled 261.35 tCO2e, compared to 182.65 tCO2e in FY25.

Water withdrawal increased significantly to 63,245 kilolitres from 37,727 kilolitres in FY25, sourced entirely from third-party suppliers. Total waste generated decreased to 92.5 tonnes, primarily driven by a sharp reduction in battery waste from 20.00 tonnes in FY25 to 2.37 tonnes in FY26. Biomedical waste remained stable at 87.68 tonnes.

Social Governance

The company spent ₹23.92 crore on employee well-being measures, representing 0.35% of total revenue, down from 0.47% in FY25. It reported zero fatalities and zero lost-time injuries during the year. The board includes one female director, constituting 33.33% of the total board strength.

What the Numbers Show

Related party sales accounted for 8.47% of total turnover in FY26, rising from 6.13% in FY25. This indicates a growing concentration of revenue within the group structure, with related party sales reaching ₹585.18 crore against a total turnover of ₹6,909.47 crore.